Skip to content

Clinical trials

Completed Phase 2 Rhabdomyosarcoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Rhabdomyosarcoma Phase: Phase 2 Status: Completed Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20023
20032
20051
20062
20074
20082
20091
20102
20111
20123
20141
20152
20161
20174
20182
20191
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed41

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)16
European Organisation for Research and Treatment of Cancer - EORTC4
Memorial Sloan Kettering Cancer Center3
Children's Oncology Group2
Eli Lilly and Company2
Sarcoma Alliance for Research through Collaboration2
Cardinal Health 414, LLC1
Centre Oscar Lambret1
Children's National Research Institute1
City of Hope Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Rhabdomyosarcoma41
Sarcoma31
Osteosarcoma18
Sarcoma, Ewing17
Neuroblastoma14
Neuroectodermal Tumors, Primitive, Peripheral13
Sarcoma, Synovial13
Liposarcoma12
Fibrosarcoma11
Leiomyosarcoma11

Trials

Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.